Therefore, to explore the role of K+ efflux in PmCQ2-induced NLRP3 inflammasome activation, different K+ channel inhibitors including KCl, Quinine and Glibenclamide were used to pretreat macrophages prior to infection to inhibit potassium efflux. The gene discussed is NLRP3; the disease is infection.